期刊
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
卷 78, 期 3, 页码 498-+出版社
MOSBY-ELSEVIER
DOI: 10.1016/j.jaad.2017.10.026
关键词
Carvajal syndrome; EKC syndrome; ichthyosis; keratoderma; orphan disease; personalized medicine; pustular psoriasis; SAM syndrome; Th1; Th17; therapeutic repurposing; therapy; ustekinumab; woolly hair
类别
资金
- Foglia Family Foundation Endowment
Background: The immune abnormalities underlying the ichthyoses are poorly understood. Objective: To determine the immunophenotype of an ichthyosis resulting from mutations in the spectrin repeat 6 (SR6) domain of desmoplakin gene (DSP) and target therapy on the basis of molecular pathogenesis. Methods: Immunophenotyping was performed by using the blood and skin of a girl with SR6 region DSP mutations causing erythroderma/ichthyosis and cardiomyopathy. Results: On the basis of the discovery of T helper 1 and T helper 17/interleukin 23 skewing in the skin and T helper 17/interleukin 22 skewing in blood, ustekinumab therapy was initiated. Ustekinumab was also administered to a boy with an SR6 region DSP mutation and ichthyosis without cardiomyopathy. Both children responded despite previous poor responses to immunosuppressants and retinoids. Limitations: Small number of patients and immunophenotyping in only 1 patient. Conclusion: An understanding of the molecular basis of inflammation in rare cutaneous disorders can lead to targeted therapy, which promises to be more beneficial than broad immunosuppressants.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据